Javascript must be enabled to continue!
Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin® H cream) and miconazole/hydrocortisone cream (Daktacort® cream) in infected eczema
View through CrossRef
AbstractAimTo study the efficacy, tolerability and acceptability of 2% fusidic acid and 1% hydrocortisone with 2% miconazole and 1% hydrocortisone.SubjectAtopic dermatitis and topical therapy with antibacterial/antiinflammatory or antifungal/antiinflammatory remedies.MethodsA randomised, open, parallel group comparison.Results207 patients with clinically infected eczema were included in a trial with either 2% fusidic acid and 1% hydrocortisone or 2% miconazole and 1% hydrocortisone. At the end of treatment, there was no statistically significant difference between treatments in the preparations of patients “cleared” or “markedly improved” (fusidic acid 69.5%, miconazole 68.6%).After 1 week treatment, there was a statistically significant difference in the overall treatment response in favour of fusidic acid/hydrocortisone cream (P = 0.04). Fusidic acid/hydrocortisone cream was significantly more effective than miconazole/hydrocortisone cream at 1 week in reducing the total sign score (P = 0.001), erythema (P = 0.002), induration (P = 0.001), dryness/scaling (P = 0.02). and cracking/fissuring (P = 0.01). Fusidic acid/hydrocortisone cream was significantly more effective bacleriologically than miconazole/hydrocortisone cream (P = 0.04), Patients considered that treatment‐related irritation was significantly more common with fusidic acid/hydrocortisone cream (P = 0.03).Adverse events were recorded in 7 (7.3%) patients given fusidic acid/hydrocortisone and in 8 (7.5%) patients given miconazole/hydrocortisone cream and contributed to treatment withdrawal in 1 (1.0%) patient given fusidic acid/hydrocortisone cream and in 3 (2.8%) patients given miconazole/hydrocortisone cream.ConclusionFusidic acid/hydrocortisone cream and miconazole/hydrocortisone cream were equally effective in treating clinically infected eczema. However, fusidic acid/hydrocortisone cream produced a significantly more rapid clinical improvement and was more effective bacteriologically. Both treatments were well tolerated.
Title: Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin® H cream) and miconazole/hydrocortisone cream (Daktacort® cream) in infected eczema
Description:
AbstractAimTo study the efficacy, tolerability and acceptability of 2% fusidic acid and 1% hydrocortisone with 2% miconazole and 1% hydrocortisone.
SubjectAtopic dermatitis and topical therapy with antibacterial/antiinflammatory or antifungal/antiinflammatory remedies.
MethodsA randomised, open, parallel group comparison.
Results207 patients with clinically infected eczema were included in a trial with either 2% fusidic acid and 1% hydrocortisone or 2% miconazole and 1% hydrocortisone.
At the end of treatment, there was no statistically significant difference between treatments in the preparations of patients “cleared” or “markedly improved” (fusidic acid 69.
5%, miconazole 68.
6%).
After 1 week treatment, there was a statistically significant difference in the overall treatment response in favour of fusidic acid/hydrocortisone cream (P = 0.
04).
Fusidic acid/hydrocortisone cream was significantly more effective than miconazole/hydrocortisone cream at 1 week in reducing the total sign score (P = 0.
001), erythema (P = 0.
002), induration (P = 0.
001), dryness/scaling (P = 0.
02).
and cracking/fissuring (P = 0.
01).
Fusidic acid/hydrocortisone cream was significantly more effective bacleriologically than miconazole/hydrocortisone cream (P = 0.
04), Patients considered that treatment‐related irritation was significantly more common with fusidic acid/hydrocortisone cream (P = 0.
03).
Adverse events were recorded in 7 (7.
3%) patients given fusidic acid/hydrocortisone and in 8 (7.
5%) patients given miconazole/hydrocortisone cream and contributed to treatment withdrawal in 1 (1.
0%) patient given fusidic acid/hydrocortisone cream and in 3 (2.
8%) patients given miconazole/hydrocortisone cream.
ConclusionFusidic acid/hydrocortisone cream and miconazole/hydrocortisone cream were equally effective in treating clinically infected eczema.
However, fusidic acid/hydrocortisone cream produced a significantly more rapid clinical improvement and was more effective bacteriologically.
Both treatments were well tolerated.
Related Results
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Antifungi Pattern of Candida Species Isolated From the Children Diapers in Obafemi Awolowo University Teaching Hospital Complex, Nigeria
Antifungi Pattern of Candida Species Isolated From the Children Diapers in Obafemi Awolowo University Teaching Hospital Complex, Nigeria
Candidiasis is by far the most common type of yeast infection, these fungi live on all surfaces of our bodies, under certain conditions, they can become so numerous to cause infect...
Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
Aim of the study: Hydrocortisone is a soft steroid with low
anti-inflammatory properties and a short duration of action, used to
manage several ocular conditions. The clinical bene...
Using Patch Testing to Improve Therapeutic Outcome in the Treatment of Hand Eczema in Vietnamese Patients
Using Patch Testing to Improve Therapeutic Outcome in the Treatment of Hand Eczema in Vietnamese Patients
BACKGROUND: Hand eczema is a common chronic and relapsing skin disease with various clinical features. Hand eczema aetiology can be allergic contact dermatitis (ACD), irritant cont...
Association of psoriasis with allergic multimorbidity of asthma, rhinitis, and eczema among adolescents: a cross-sectional study
Association of psoriasis with allergic multimorbidity of asthma, rhinitis, and eczema among adolescents: a cross-sectional study
Abstract
Background
Associations between psoriasis and allergic diseases (asthma, rhinitis, and eczema) in children have been reported in a limited ...
1280Natural history, developmental trajectories, and determinants of eczema from infancy to 26 years of age
1280Natural history, developmental trajectories, and determinants of eczema from infancy to 26 years of age
Abstract
Background
Eczema is a common inflammatory skin disease with varying developmental trajectories/patterns. This study so...
Hand eczema: possible risks and choice of therapy
Hand eczema: possible risks and choice of therapy
Hand eczema is a common disease – up to 5% in the general population. In addition, eczema is closely related to atopy and, like atopic dermatitis, to a mutation in the FLG gene. In...
Analytical Method Development and Validation of Beclomethasone Dipropionate and Fusidic Acid in pure and Pharmaceutical Dosage Form (Cream) by RP-HPLC
Analytical Method Development and Validation of Beclomethasone Dipropionate and Fusidic Acid in pure and Pharmaceutical Dosage Form (Cream) by RP-HPLC
A simple, rapid, specific, cheap, eco-friendly, and accurate RP-HPLC method for simultaneous estimation of Beclomethasone Dipropionate and Fusidic Acid in pure and combination drug...


